Senior Medical Affairs Lead, Prostate Cancer

Curium Pharma; Boston (MA); Vor Ort; USD 150.000 - 210.000; Vollzeit

Benefits dieser Stelle

Remote work acceptable

Up to 25% travel

Zusammenfassung

Curium is seeking an Associate Director of Medical Affairs focused on prostate cancer to lead scientific content, medical planning, and cross-functional collaboration. You will translate complex data into concise, compliant deliverables and support launch readiness and evidence generation across radioligand, imaging, and oncology portfolios.

The role requires strong scientific writing, project management, and stakeholder engagement, with exposure to medical strategy and potential growth into

Qualifikationen

• Advanced degree in a scientific/clinical discipline (PharmD, PhD, MD or MS).
• 5+ years in healthcare consulting, medical communications, scientific communications, or Medical Affairs.
• Experience managing multiple scientific projects, stakeholders, and deadlines in consulting/Medical Affairs.
• Experience developing scientific and strategic deliverables (plans, platforms, decks, publications, materials).
• Experience in oncology, radiopharmaceuticals, or nuclear medicine preferred.

Aufgaben

• Develop medical plans, launch plans, timelines, and leadership presentations.
• Create scientific content, slide decks, executive briefs, and training materials.
• Support publication planning, evidence generation, advisory boards, and meetings.
• Manage multiple projects and collaborate with cross-functional teams.
• Develop dashboards in Power BI/Tableau to track Medical Affairs activities.

Kenntnisse

Scientific writing

Project management

Communication skills

PowerPoint

Power BI

Tableau

Ausbildung

PharmD/PhD/MD/MS

Tools

Power BI

Tableau

Jobbeschreibung

Curium is seeking an Associate Director of Medical Affairs focused on prostate cancer to lead scientific content, medical planning, and cross-functional collaboration. You will translate complex data into concise, compliant deliverables and support launch readiness and evidence generation across radioligand, imaging, and oncology portfolios.

The role requires strong scientific writing, project management, and stakeholder engagement, with exposure to medical strategy and potential growth into